BRPI0611827A2 - Nanoparticle manufacturing methods, systems and materials - Google Patents

Nanoparticle manufacturing methods, systems and materials

Info

Publication number
BRPI0611827A2
BRPI0611827A2 BRPI0611827-5A BRPI0611827A BRPI0611827A2 BR PI0611827 A2 BRPI0611827 A2 BR PI0611827A2 BR PI0611827 A BRPI0611827 A BR PI0611827A BR PI0611827 A2 BRPI0611827 A2 BR PI0611827A2
Authority
BR
Brazil
Prior art keywords
materials
systems
nanoparticles
manufacturing methods
nanoparticle manufacturing
Prior art date
Application number
BRPI0611827-5A
Other languages
Portuguese (pt)
Inventor
Joseph M Desimone
Jason P Rolland
Ansley E Exner
Edward T Samulski
R Jude Samulski
Benjamin W Maynor
Larken E Euliss
Stephanie Gratton
Alex Ermosh
Andrew James Murphy
Ginger Denison Rothrock
Original Assignee
Univ North Carolina State
Liquidia Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ North Carolina State, Liquidia Technologies Inc filed Critical Univ North Carolina State
Priority claimed from PCT/US2006/023722 external-priority patent/WO2007024323A2/en
Publication of BRPI0611827A2 publication Critical patent/BRPI0611827A2/en

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

MÉTODOS, SISTEMAS E MATERIAIS DE FABRICAÇçO DE NANOPARTÍCULA. Nanopartículas são moldadas em moldes de escala nano fabricados de materiais poliméricos de baixa energia de superfície incapazes de serem umedecido. As nanopartículas podem incluir composições farmacêuticas, taggants, agentes de contraste, medicamentos biológicos, composições de medicamento, materiais orgânicos e outros. Os moldes podem ser virtualmente qualquer formato de menos que 10 mícrons em um diâmetro transverso.METHODS, SYSTEMS AND MATERIALS FOR MANUFACTURING NANOParticles. Nanoparticles are molded into nano-scale molds made of low-surface, non-wetting polymeric materials. Nanoparticles may include pharmaceutical compositions, taggants, contrast agents, biological drugs, drug compositions, organic materials and the like. The molds can be virtually any shape of less than 10 microns in a transverse diameter.

BRPI0611827-5A 2005-06-17 2006-06-19 Nanoparticle manufacturing methods, systems and materials BRPI0611827A2 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US69160705P 2005-06-17 2005-06-17
US71496105P 2005-09-07 2005-09-07
US76280206P 2006-01-27 2006-01-27
US79987606P 2006-05-12 2006-05-12
PCT/US2006/023722 WO2007024323A2 (en) 2005-06-17 2006-06-19 Nanoparticle fabrication methods, systems, and materials

Publications (1)

Publication Number Publication Date
BRPI0611827A2 true BRPI0611827A2 (en) 2008-12-02

Family

ID=40535672

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0611827-5A BRPI0611827A2 (en) 2005-06-17 2006-06-19 Nanoparticle manufacturing methods, systems and materials

Country Status (1)

Country Link
BR (1) BRPI0611827A2 (en)

Similar Documents

Publication Publication Date Title
WO2007024323A3 (en) Nanoparticle fabrication methods, systems, and materials
Aziz et al. Manufactures of bio‐degradable and bio‐based polymers for bio‐materials in the pharmaceutical field
Lvov et al. The application of halloysite tubule nanoclay in drug delivery
WO2008129106A3 (en) Nanoparticles comprising a cyclodextrin and a biologically active molecule and uses thereof
Muldoon et al. High precision 3D printing for micro to nano scale biomedical and electronic devices
WO2008045486A3 (en) Nanoparticle compositions for controlled delivery of nucleic acids
Lekshmi et al. Recent progress in carbon nanotube polymer composites in tissue engineering and regeneration
EP2363156A3 (en) Method of fabricating biodegradable medical devices with enhanced mechanical strength and pharmacological functions
BRPI0512829A (en) preparation of pharmaceutical compositions containing nanoparticles
DE602006008649D1 (en) ORGANIC INORGANIC HYBRID PARTICLE MATERIAL AND POLYMER COMPOSITIONS CONTAINING THEREOF
WO2008063204A3 (en) Taggants and methods and systems for fabricating
WO2005112886A3 (en) Methods and articles for the delivery of therapeutic agents
BRPI0416239A (en) method for preparing paclitaxel submicron particles
HK1124627A1 (en) Polyglutamate-amino acid conjugates and methods
ATE433961T1 (en) ANSAMYCINS WITH IMPROVED PHARMACOLOGICAL AND BIOLOGICAL PROPERTIES
EP2399970A3 (en) Nanocomposites
WO2007133808A3 (en) Nano-particles for cosmetic applications
Ryu et al. Dry tablet formulation of PLGA nanoparticles with a preocular applicator for topical drug delivery to the eye
DE602005012289D1 (en) DISTRIBUTION VEHICLES WITH NANOTEILES
CL2009001080A1 (en) Process for encapsulating biologically active agents in a particulate carrier, comprising solubilizing in a hydrophobic ion pairing agent and a solvent, dissolving, emulsifying, and obtaining the carrier; vehicle in the form of particles; and pharmaceutical composition comprising the vehicle.
ATE505508T1 (en) MEDICINAL DELIVERY DEVICE CONTAINING AN ACTIVE SUBSTANCE AND METHOD FOR RELEASING AN ACTIVE SUBSTANCE FROM A MEDICINAL DELIVERY DEVICE
Vargas-Molinero et al. Hybrid systems of nanofibers and polymeric nanoparticles for biological application and delivery systems
BRPI0614080A2 (en) COMPOSITION AND METHOD FOR THE PREPARATION OF A NANOPARTICULATE cephalosporin, FOR THE TREATMENT OF BACTERIAL DISEASE AND FOR THE PREVENTION AND/OR TREATMENT OF OSTEOPOROSIS
Hong et al. Physical interactions of nanoparticles with biological membranes: The observation of nanoscale hole formation
AR064104A1 (en) DOSAGE FORMS IN VALSARTAN MICROEMULSION, AND METHODS TO PREPARE THEM

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Owner name: THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (U

B06T Formal requirements before examination [chapter 6.20 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B11E Dismissal acc. art. 34 of ipl - requirements for examination incomplete
B11T Dismissal of application maintained [chapter 11.20 patent gazette]